Cibc Asset Management Inc Abbott Laboratories Transaction History

Cibc Asset Management Inc

$28.3 Billion
Q3 2024

A detailed history of Cibc Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Cibc Asset Management Inc holds 696,651 shares of ABT stock, worth $79.1 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

696,651

Previous 681,943 2.16%

Holding current value

$79.1 Million

Previous $70.9 Million 12.09%

% of portfolio

0.28%

Previous 0.27%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$100.07 - $118.13 $1.47 Million - $1.74 Million	14,708 Added 2.16%	696,651 $79.4 Million
Q2 2024 Aug 01, 2024	BUY	$100.73 - $112.44 $1.69 Million - $1.89 Million	16,794 Added 2.52%	681,943 $70.9 Million
Q1 2024 May 09, 2024	BUY	$109.52 - $120.96 $1.02 Million - $1.13 Million	9,329 Added 1.42%	665,149 $75.6 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $360,940 - $441,820	-4,002 Reduced 0.61%	655,820 $72.2 Million
Q3 2023 Oct 30, 2023	SELL	$95.53 - $114.62 $2.01 Million - $2.41 Million	-21,023 Reduced 3.09%	659,822 $63.9 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $397,778 - $443,208	-3,947 Reduced 0.58%	680,845 $74.2 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $5.59 Million - $6.58 Million	57,745 Added 9.21%	684,792 $69.3 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $33.4 Million - $39.2 Million	351,619 Added 127.66%	627,047 $68.9 Million
Q3 2022 Nov 03, 2022	BUY	$96.76 - $112.03 $1.76 Million - $2.03 Million	18,152 Added 7.06%	275,428 $26.7 Million
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $1.79 Million - $2.16 Million	17,527 Added 7.31%	257,276 $28 Million
Q1 2022 May 06, 2022	BUY	$114.02 - $139.04 $3.52 Million - $4.3 Million	30,895 Added 14.79%	239,749 $28.4 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $1.04 Million - $1.27 Million	8,976 Added 4.49%	208,854 $29.4 Million
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $800,054 - $885,093	6,858 Added 3.55%	199,878 $23.6 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $5,395 - $6,351	-51 Reduced 0.03%	193,020 $22.4 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $571,954 - $673,848	5,255 Added 2.8%	193,071 $23.1 Million
Q4 2020 Feb 03, 2021	BUY	$105.0 - $114.42 $837,165 - $912,270	7,973 Added 4.43%	187,816 $20.6 Million
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $809,456 - $983,024	8,833 Added 5.17%	179,843 $19.6 Million
Q2 2020 Jul 28, 2020	BUY	$76.57 - $98.0 $406,892 - $520,772	5,314 Added 3.21%	171,010 $15.6 Million
Q1 2020 Apr 30, 2020	BUY	$62.82 - $91.86 $878,160 - $1.28 Million	13,979 Added 9.21%	165,696 $13.1 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $8,086 - $9,002	-103 Reduced 0.07%	151,717 $13.2 Million
Q3 2019 Oct 30, 2019	SELL	$81.84 - $88.74 $74,310 - $80,575	-908 Reduced 0.59%	151,820 $12.7 Million
Q2 2019 Aug 05, 2019	SELL	$72.88 - $85.0 $24,997 - $29,155	-343 Reduced 0.22%	152,728 $12.8 Million
Q1 2019 May 06, 2019	SELL	$66.22 - $80.06 $298,387 - $360,750	-4,506 Reduced 2.86%	153,071 $12.2 Million
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $99,585 - $112,816	-1,519 Reduced 0.95%	157,577 $11.4 Million
Q3 2018 Nov 02, 2018	SELL	$60.81 - $73.36 $74,553 - $89,939	-1,226 Reduced 0.76%	159,096 $11.7 Million
Q2 2018 Aug 09, 2018	BUY	$57.57 - $63.54 $418,130 - $461,491	7,263 Added 4.75%	160,322 $9.78 Million
Q1 2018 Apr 30, 2018	SELL	$56.27 - $63.62 $403,624 - $456,346	-7,173 Reduced 4.48%	153,059 $9.17 Million
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $90,343 - $96,722	-1,683 Reduced 1.04%	160,232 $9.14 Million
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $7.78 Million - $8.69 Million	161,915	161,915 $8.64 Million

Others Institutions Holding ABT

# of Institutions

3,196

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Account

Cibc Asset Management Inc Abbott Laboratories Transaction History